3.4.21.72: IgA-specific serine endopeptidase
This is an abbreviated version!
For detailed information about IgA-specific serine endopeptidase, go to the full flat file.
Word Map on EC 3.4.21.72
-
3.4.21.72
-
neisseria
-
haemophilus
-
streptococcus
-
influenzae
-
gonorrhoeae
-
hinge
-
meningitidis
-
sanguis
-
autotransporter
-
pneumococcal
-
gonococcal
-
serogroups
-
meningococci
-
oralis
-
medicine
-
protease-producing
-
lactamica
-
nontypeable
-
paraproteins
-
ramosum
-
enzyme-neutralizing
-
urealyticum
-
pharmacology
-
agriculture
-
drug development
-
analysis
- 3.4.21.72
- neisseria
- haemophilus
- streptococcus
- influenzae
- gonorrhoeae
- hinge
- meningitidis
- sanguis
-
autotransporter
- pneumococcal
-
gonococcal
-
serogroups
-
meningococci
- oralis
- medicine
-
protease-producing
- lactamica
-
nontypeable
-
paraproteins
- ramosum
-
enzyme-neutralizing
- urealyticum
- pharmacology
- agriculture
- drug development
- analysis
Reaction
Cleavage of immunoglobulin A molecules at certain Pro-/- bonds in the hinge region. No small molecule substrates are known =
Synonyms
Iga, IgA protease, IgA protease A1, IgA protease B2, IgA proteinase, IgA-specific proteinase, IgA1 protease, IgA1-protease, IgA1-specific protease, IgA1?P, IgA1P, IgA1pr, IgaA1, IgaA2, IgaB2, IgAP, Immunoglobulin A protease, Immunoglobulin A proteinase, immunoglobulin A1 protease, NMB IgA1 protease, Proteinase, immunoglobulin A, serine-type IgA1 protease, serine-type immunoglobulin A1 protease, ST-11 IgA protease, type 2 IgA1 protease
ECTree
3.4.21.72 IgA-specific serine endopeptidaseAdvanced search results
results (
results (Substrates Products
Substrates Products on EC 3.4.21.72 - IgA-specific serine endopeptidase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
top
SUBSTRATE 
PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate)
(Substrate)
LITERATURE
(Substrate)
(Substrate)
COMMENTARY
(Product)
(Product)
LITERATURE
(Product)
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
r=reversible
ir=irreversible
?=not specified
degalactosylated IgA1 + H2O
immunglobulin Fc + immunglobulin Fd
-
artificial substrate, high activity
-
-
?
desialylated and degalactosylated immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
desialylated/degalactosylated immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
-
artificial substrate, high activity
-
-
?
immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fab
-
cleavage of the hinge region
-
-
?
immunoglobulin A1 + H2O
oligopeptides derived from immunoglobulin A1
IgA proteases only cleave the proline, serine and threonine rich hinge peptide unique to immunoglobulin A1
-
-
?
surface-exposed SD domain + H2O
?
the enzyme cleaves its own isolated recombinant SD domain, single or linked with the alpha-protein, giving the L1 domain
-
-
?
aberrantly glycosylated immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
-
pathogenic human aberrantly glycosylated IgA1
-
-
?
aberrantly glycosylated immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
-
pathogenic human aberrantly glycosylated immunglobulin A1
-
-
?
aberrantly glycosylated immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
-
pathogenic human aberrantly glycosylated IgA1
-
-
?
aberrantly glycosylated immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
Neisseria gonorrhoeae ATCC 49226
-
pathogenic human aberrantly glycosylated IgA1
-
-
?
aberrantly glycosylated immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
-
pathogenic human aberrantly glycosylated IgA1
-
-
?
aberrantly glycosylated immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
Neisseria meningitidis ATCC 13090
-
pathogenic human aberrantly glycosylated IgA1
-
-
?
degalactosylated immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
-
artificial substrate, high activity
-
-
?
degalactosylated immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
-
artificial substrate, high activity
-
-
?
desialylated and degalactosylated immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
-
artificial substrate, high activity
-
-
?
desialylated and degalactosylated immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
-
artificial substrate, high activity
-
-
?
desialylated and degalactosylated immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
-
artificial substrate, high activity
-
-
?
desialylated IgA1 + H2O
immunglobulin Fc + immunglobulin Fd
-
artificial substrate
-
-
?
desialylated IgA1 + H2O
immunglobulin Fc + immunglobulin Fd
-
artificial substrate
-
-
?
desialylated immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
-
artificial substrate
-
-
?
desialylated immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
-
artificial substrate
-
-
?
human IgA1 + H2O
?
culture supernatants from all strains tested cause degradation of human IgA1
-
-
?
human IgA1 + H2O
?
-
IgA1 protease is a proteolytic enzyme with strict substrate specificity for human IgA1
-
-
?
human IgA1 + H2O
?
the enzyme specifically cleaves the hinge region of human IgA1, the predominant class of immunoglobulin present on mucosal membranes
-
-
?
human IgA1 + H2O
?
unique cleavage specificity of the NTHI IgA1 protease
-
-
?
human IgA1 + H2O
?
deglycosylated human IgA1, the IgA1 protease cleaves two peptide bonds within the human IgA1 hinge region at replicate sequences, cleavage of human IgA1 produces two different sized Fc fragments with N-terminal sequence Thr-Pro-Ser-Pro-Ser
-
-
?
human IgA1 + H2O
?
-
human IgA1 possesses a unique hinge region composed of a repeated sequence rich in proline, serine and threonine, which are the specific cleavage sites of IgA1 protease
-
-
?
human IgA1 + H2O
?
-
IgA1 protease is a proteolytic enzyme with strict substrate specificity for human IgA1
-
-
?
human IgA1 + H2O
?
-
human IgA1 possesses a unique hinge region composed of a repeated sequence rich in proline, serine and threonine, which are the specific cleavage sites of IgA1 protease
-
-
?
human IgA1 + H2O
?
-
IgA1 protease is a proteolytic enzyme with strict substrate specificity for human IgA1
-
-
?
human IgA1 + H2O
?
-
the enzyme possesses a unique substrate specificity to immunoglobulin A1
-
-
?
human IgA1 + H2O
?
-
human IgA1 possesses a unique hinge region composed of a repeated sequence rich in proline, serine and threonine, which are the specific cleavage sites of IgA1 protease
-
-
?
human immunoglobulin A1 + H2O
?
bacterial isolates show wide variability in IgA1 protease activity, and those isolated from patients with clinical infection possess the highest levels of activity, overview
-
-
?
human immunoglobulin A1 + H2O
?
site-specific proteolytic cleavage
-
-
?
human immunoglobulin A1 + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
-
-
-
?
human immunoglobulin A1 + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
-
-
-
?
human immunoglobulin A1 + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
-
-
-
?
human immunoglobulin A1 + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
-
-
-
?
human immunoglobulin A1 + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
-
-
-
?
human lamp-1 + H2O
?
-
substrate from chang human conjunctiva cells ATCC CCL20.2, human bladder carcinoma cells RT112, JOSK-M cells, DSM ACC30, myelomonocytic cell line, HL60 cells, DSM ACC3, myelocytic cell line
-
?
human lamp-1 + H2O
?
-
substrate from chang human conjunctiva cells ATCC CCL20.2, human bladder carcinoma cells RT112, JOSK-M cells, DSM ACC30, myelomonocytic cell line, HL60 cells, DSM ACC3, myelocytic cell line
-
?
IgA2-IgA1 half hinge + H2O
?
-
a hybrid comprised of human IgA2 bearing half of the human IgA1 hinge region, pH 7.2, 37°C, 24% of the substrate is cleaved after 24 h incubation
-
-
?
IgA2-IgA1 half hinge + H2O
?
-
a hybrid comprised of human IgA2 bearing half of the human IgA1 hinge region, pH 7.2, 37°C, 27% of the substrate is cleaved after 24 h incubation
-
-
?
IgA2-IgA1 half hinge + H2O
?
-
a hybrid comprised of human IgA2 bearing half of the human IgA1 hinge region, pH 7.2, 37°C, 50% of the substrate is cleaved after 24 h incubation
-
-
?
IgA2-IgA1 half hinge + H2O
?
-
a hybrid comprised of human IgA2 bearing half of the human IgA1 hinge region, pH 7.2, 37°C, 85% of the substrate is cleaved after 24 h incubation
-
-
?
IgA2-IgA1 half hinge + H2O
?
a hybrid comprised of human IgA2 bearing half of the human IgA1 hinge region, pH 7.2, 37°C, 21% of the substrate is cleaved after 24 h incubation
-
-
?
IgA2-IgA1 half hinge + H2O
?
a hybrid comprised of human IgA2 bearing half of the human IgA1 hinge region, pH 7.2, 37°C, 40% of the substrate is cleaved after 24 h incubation
-
-
?
IgA2-IgA1 half hinge + H2O
?
-
a hybrid comprised of human IgA2 bearing half of the human IgA1 hinge region, pH 7.2, 37°C, 25% of the substrate is cleaved after 24 h incubation
-
-
?
IgA2-IgA1 half hinge + H2O
?
-
a hybrid comprised of human IgA2 bearing half of the human IgA1 hinge region, pH 7.2, 37°C, 25% of the substrate is cleaved after 24 h incubation
-
-
?
IgA2-IgA1 half hinge + H2O
?
-
a hybrid comprised of human IgA2 bearing half of the human IgA1 hinge region, pH 7.2, 37°C, 30% of the substrate is cleaved after 24 h incubation
-
-
?
IgA2-IgA1 half hinge + H2O
?
-
a hybrid comprised of human IgA2 bearing half of the human IgA1 hinge region, pH 7.2, 37°C, 4% of the substrate is cleaved after 24 h incubation
-
-
?
IgA2-IgA1 half hinge + H2O
?
-
a hybrid comprised of human IgA2 bearing half of the human IgA1 hinge region, pH 7.2, 37°C, 30% of the substrate is cleaved after 24 h incubation
-
-
?
IgA2-IgA1 half hinge + H2O
?
-
a hybrid comprised of human IgA2 bearing half of the human IgA1 hinge region, pH 7.2, 37°C, 30% of the substrate is cleaved after 24 h incubation
-
-
?
IgA2-IgA1 half hinge + H2O
?
-
a hybrid comprised of human IgA2 bearing half of the human IgA1 hinge region, pH 7.2, 37°C, 30% of the substrate is cleaved after 24 h incubation
-
-
?
immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
-
-
-
-
?
immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
-
human IgA1, cleavage at the hinge region
-
-
?
immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
-
human myeloma IgA1
-
-
?
immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
-
human myeloma immunglobulin A1
-
-
?
immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
Haemophilus influenzae ATCC 10211
-
-
-
-
?
immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
Haemophilus influenzae ATCC 49247
-
human IgA1, cleavage at the hinge region
-
-
?
immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
Haemophilus influenzae ATCC 49247
-
-
-
-
?
immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
-
cleavage of the hinge region
-
-
?
immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
-
human myeloma IgA1
-
-
?
immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
Neisseria gonorrhoeae ATCC 49226
-
-
-
-
?
immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
Neisseria gonorrhoeae ATCC 49226
-
human myeloma IgA1
-
-
?
immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
-
human myeloma IgA1
-
-
?
immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
Neisseria meningitidis ATCC 13090
-
-
-
-
?
immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
Neisseria meningitidis ATCC 13090
-
human myeloma IgA1
-
-
?
immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
-
IgA1 from human serum
-
-
?
immunglobulin A1 + H2O
immunglobulin Fc + immunglobulin Fd
-
IgA1 from human serum
-
-
?
immunoglobulin A + H2O
?
-
IgA 1 proteases are a family of bacterial enzymes specifically cleaving human IgA, the immunoglobulin for antibody defense of mucosal surfaces
-
-
?
immunoglobulin A + H2O
?
-
IgA hydrolysis may allow the microbes to circumvent immunity, or possibly even recruit antibodies or their fragments as a step in the infectious process
-
-
?
immunoglobulin A + H2O
?
-
IgA 1 proteases are a family of bacterial enzymes specifically cleaving human IgA, the immunoglobulin for antibody defense of mucosal surfaces
-
-
?
immunoglobulin A + H2O
?
-
IgA hydrolysis may allow the microbes to circumvent immunity, or possibly even recruit antibodies or their fragments as a step in the infectious process
-
-
?
immunoglobulin A + H2O
?
-
IgA 1 proteases are a family of bacterial enzymes specifically cleaving human IgA, the immunoglobulin for antibody defense of mucosal surfaces
-
-
?
immunoglobulin A + H2O
?
-
IgA hydrolysis may allow the microbes to circumvent immunity, or possibly even recruit antibodies or their fragments as a step in the infectious process
-
-
?
immunoglobulin A + H2O
?
-
IgA hydrolysis may allow the microbes to circumvent immunity, or possibly even recruit antibodies or their fragments as a step in the infectious process
-
-
?
immunoglobulin A + H2O
?
-
IgA 1 proteases are a family of bacterial enzymes specifically cleaving human IgA, the immunoglobulin for antibody defense of mucosal surfaces
-
-
?
immunoglobulin A + H2O
?
-
IgA hydrolysis may allow the microbes to circumvent immunity, or possibly even recruit antibodies or their fragments as a step in the infectious process
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
-
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
-
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
-
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
all bacterial IgA1 proteases cleave the heavy chain of IgA1, both serum and secretory IgA2 proteins are IgA1 protease-resistant
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
Streptococcus sanguis, Streptococcus pneumoniae and Neisseria gonorrhoeae all release IgA1 proteases each cleaving a single peptide bond, Neisseria meningitidis and Haemophilus influenzae release multiple enzyme types differing in the specific peptide bonds hydrolyzed, e.g. random clinical isolates of Neisseria meningitidis release either type 1 and type 2 protease, type 1 cleaving peptide 237-238 and type 2 cleaving 235-236 in the IgA hinge
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
Haemophilus influenzae type 1 enzyme cleaves Pro231-Ser232, type 2 enzyme cleaves Pro235-Thr236, type 3 enzyme cleaves peptide bond 237-238
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
peptide analogs of human IgA as protease substrates
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
Haemophilus influenzae enzyme has at least 2 cleavage types. Serogroups, type 1 in serotypes a, b, d, f. Type 2 in c and e
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
human myeloma immunoglobulin
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
-
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
all bacterial IgA1 proteases cleave the heavy chain of IgA1, both serum and secretory IgA2 proteins are IgA1 protease-resistant
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
Streptococcus sanguis, Streptococcus pneumoniae and Neisseria gonorrhoeae all release IgA1 proteases each cleaving a single peptide bond, Neisseria meningitidis and Haemophilus influenzae release multiple enzyme types differing in the specific peptide bonds hydrolyzed, e.g. random clinical isolates of Neisseria meningitidis release either type 1 and type 2 protease, type 1 cleaving peptide 237-238 and type 2 cleaving 235-236 in the IgA hinge
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
peptide analogs of human IgA as protease substrates
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
specific for human immunoglobulin IgA1
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
Neisseria gonorrhoeae cleaves peptide bond 235-236
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
human myeloma immunoglobulin
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
-
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
all bacterial IgA1 proteases cleave the heavy chain of IgA1, both serum and secretory IgA2 proteins are IgA1 protease-resistant
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
Streptococcus sanguis, Streptococcus pneumoniae and Neisseria gonorrhoeae all release IgA1 proteases each cleaving a single peptide bond, Neisseria meningitidis and Haemophilus influenzae release multiple enzyme types differing in the specific peptide bonds hydrolyzed, e.g. random clinical isolates of Neisseria meningitidis release either type 1 and type 2 protease, type 1 cleaving peptide 237-238 and type 2 cleaving 235-236 in the IgA hinge
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
peptide analogs of human IgA as protease substrates
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
cleaves a Pro-Ser bond in the hinge region of the alpha1 chain between residues 223 and 224
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
specific for human immunoglobulin IgA1
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
-
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
all bacterial IgA1 proteases cleave the heavy chain of IgA1, both serum and secretory IgA2 proteins are IgA1 protease-resistant
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
Streptococcus sanguis, Streptococcus pneumoniae and Neisseria gonorrhoeae all release IgA1 proteases each cleaving a single peptide bond, Neisseria meningitidis and Haemophilus influenzae release multiple enzyme types differing in the specific peptide bonds hydrolyzed, e.g. random clinical isolates of Neisseria meningitidis release either type 1 and type 2 protease, type 1 cleaving peptide 237-238 and type 2 cleaving 235-236 in the IgA hinge
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
peptide analogs of human IgA as protease substrates
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
-
-
-
?
Immunoglobulin A + H2O
immunoglobulin Fabalpha + immunoglobulin Fc
-
-
-
-
?
mutant hhP227S + H2O
?
-
pH 7.2, 37°C, 36% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhP227S + H2O
?
-
pH 7.2, 37°C, 54% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhP227S + H2O
?
-
pH 7.2, 37°C, 62% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhP227S + H2O
?
-
pH 7.2, 37°C, 71% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhP227S + H2O
?
pH 7.2, 37°C, 78% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhP227S + H2O
?
pH 7.2, 37°C, 81% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhP227S + H2O
?
-
pH 7.2, 37°C, 34% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhP227S + H2O
?
-
pH 7.2, 37°C, 34% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhP227S + H2O
?
-
pH 7.2, 37°C, 29% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhP227S + H2O
?
-
pH 7.2, 37°C, 4% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS224/230P + H2O
?
-
pH 7.2, 37°C, 17% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS224/230P + H2O
?
-
pH 7.2, 37°C, 35% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS224/230P + H2O
?
-
pH 7.2, 37°C, 19% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS224/230P + H2O
?
-
pH 7.2, 37°C, 22% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS224/230P + H2O
?
pH 7.2, 37°C, 4% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS224/230P + H2O
?
pH 7.2, 37°C, 7% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS224/230P + H2O
?
-
pH 7.2, 37°C, 29% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS224/230P + H2O
?
-
pH 7.2, 37°C, 29% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS224/230P + H2O
?
-
pH 7.2, 37°C, 25% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS224/230P + H2O
?
-
pH 7.2, 37°C, 31% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS224P + H2O
?
-
pH 7.2, 37°C, 19% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS224P + H2O
?
-
pH 7.2, 37°C, 67% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS224P + H2O
?
-
pH 7.2, 37°C, 41% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS224P + H2O
?
-
pH 7.2, 37°C, 51% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS224P + H2O
?
pH 7.2, 37°C, 70% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS224P + H2O
?
pH 7.2, 37°C, 74% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS224P + H2O
?
-
pH 7.2, 37°C, 58% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS224P + H2O
?
-
pH 7.2, 37°C, 20% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS224P + H2O
?
-
pH 7.2, 37°C, 49% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS230P + H2O
?
-
pH 7.2, 37°C, 13% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS230P + H2O
?
-
pH 7.2, 37°C, 14% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS230P + H2O
?
-
pH 7.2, 37°C, 28% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS230P + H2O
?
-
pH 7.2, 37°C, 7% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS230P + H2O
?
pH 7.2, 37°C, 3% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS230P + H2O
?
pH 7.2, 37°C, 7% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS230P + H2O
?
-
pH 7.2, 37°C, 27% of the substrate is cleaved after 24 h incubation
-
-
?
mutant hhS230P + H2O
?
-
pH 7.2, 37°C, 13% of the substrate is cleaved after 24 h incubation
-
-
?
NF-kappaB p65/RelA component + H2O
?
-
specific cleavage at the C-terminal region of NF-kappaB p65/RelA component within the nucleus of infected cells
-
-
?
NF-kappaB p65/RelA component + H2O
?
-
specific cleavage at the C-terminal region of NF-kappaB p65/RelA component
-
-
?
additional information
?
-
-
in vitro studies show that the enzyme also cleaves human chorionic gonadotrophin hormone, granulocyte-macrophage colony stimulating factor, the CD8 surface antigen of cytotoxic T lymphocytes and LAMP 1 a membrane glycoprotein of lysosomes
-
-
?
additional information
?
-
-
the type 2 IgA1 protease is a potential virulence factor in Haemophilus influenzae, the igaB encoded enzyme is the primary mediator of IgA1 protease activity in strain 11P6H, not the type 1 IgA1 protease encoded by igaA, IgA1 proteases are classified as type 1 or type 2 based on the specific site of enzymatic cleavage in the hinge region of the IgA1 molecule
-
-
?
additional information
?
-
-
IgA1 exists in forms of monomer, dimer, and oligomer (or polymer) in the physiological conditions and agIgA1 also exists as circulating IgA1-IgG immune complexes in patients with IgAN
-
-
?
additional information
?
-
-
immunglobulin A1 exists in forms of monomer, dimer, and oligomer (or polymer) in the physiological conditions and agimmunglobulin A1 also exists as circulating immunglobulin A1-immunglobulin G immune complexes in patients with IgAN
-
-
?
additional information
?
-
-
the IgA protease from Haemophilus influenzae strain ATCC 49247 has a high activity and the ability to degrade human in vivo deposited aberrantly glycosylated IgA1-containing immune complex
-
-
?
additional information
?
-
-
the enzyme activity is several fold higher with artificial substrates, degalactosylated IgA1 and desialylated/degalactosylated IgA1, as compared to the wild-type IgA1 substrate, while the activity with artificial desialylated IgA1 is reduced
-
-
?
additional information
?
-
-
the enzyme activity is several fold higher with artificial substrates, degalactosylated immunglobulin A1 and desialylated/degalactosylated immunglobulin A1, as compared to the wild-type immunglobulin A1 substrate, while the activity with artificial desialylated immunglobulin A1 is reduced
-
-
?
additional information
?
-
-
the enzyme performs autocatalysis at its autocleavage site
-
-
?
additional information
?
-
Haemophilus influenzae ATCC 10211
-
IgA1 exists in forms of monomer, dimer, and oligomer (or polymer) in the physiological conditions and agIgA1 also exists as circulating IgA1-IgG immune complexes in patients with IgAN
-
-
?
additional information
?
-
Haemophilus influenzae ATCC 10211
-
immunglobulin A1 exists in forms of monomer, dimer, and oligomer (or polymer) in the physiological conditions and agimmunglobulin A1 also exists as circulating immunglobulin A1-immunglobulin G immune complexes in patients with IgAN
-
-
?
additional information
?
-
Haemophilus influenzae ATCC 10211
-
the enzyme activity is several fold higher with artificial substrates, degalactosylated IgA1 and desialylated/degalactosylated IgA1, as compared to the wild-type IgA1 substrate, while the activity with artificial desialylated IgA1 is reduced
-
-
?
additional information
?
-
Haemophilus influenzae ATCC 10211
-
the enzyme activity is several fold higher with artificial substrates, degalactosylated immunglobulin A1 and desialylated/degalactosylated immunglobulin A1, as compared to the wild-type immunglobulin A1 substrate, while the activity with artificial desialylated immunglobulin A1 is reduced
-
-
?
additional information
?
-
Haemophilus influenzae ATCC 49247
-
the IgA protease from Haemophilus influenzae strain ATCC 49247 has a high activity and the ability to degrade human in vivo deposited aberrantly glycosylated IgA1-containing immune complex
-
-
?
additional information
?
-
Haemophilus influenzae ATCC 49247
-
the enzyme performs autocatalysis at its autocleavage site
-
-
?
additional information
?
-
Haemophilus influenzae ATCC 49247
-
IgA1 exists in forms of monomer, dimer, and oligomer (or polymer) in the physiological conditions and agIgA1 also exists as circulating IgA1-IgG immune complexes in patients with IgAN
-
-
?
additional information
?
-
Haemophilus influenzae ATCC 49247
-
immunglobulin A1 exists in forms of monomer, dimer, and oligomer (or polymer) in the physiological conditions and agimmunglobulin A1 also exists as circulating immunglobulin A1-immunglobulin G immune complexes in patients with IgAN
-
-
?
additional information
?
-
Haemophilus influenzae ATCC 49247
-
the enzyme activity is several fold higher with artificial substrates, degalactosylated IgA1 and desialylated/degalactosylated IgA1, as compared to the wild-type IgA1 substrate, while the activity with artificial desialylated IgA1 is reduced
-
-
?
additional information
?
-
Haemophilus influenzae ATCC 49247
-
the enzyme activity is several fold higher with artificial substrates, degalactosylated immunglobulin A1 and desialylated/degalactosylated immunglobulin A1, as compared to the wild-type immunglobulin A1 substrate, while the activity with artificial desialylated immunglobulin A1 is reduced
-
-
?
additional information
?
-
-
in vitro studies showed that the enzyme also cleaves human chorionic gonadotrophin hormone, granulocyte-macrophage colony stimulating factor, the CD8 surface antigen of cytotoxic T lymphocytes and LAMP 1 a membrane glycoprotein of lysosomes
-
-
?
additional information
?
-
-
IgA1 exists in forms of monomer, dimer, and oligomer (or polymer) in the physiological conditions and agIgA1 also exists as circulating IgA1-IgG immune complexes in patients with IgAN
-
-
?
additional information
?
-
-
the enzyme activity is several fold higher with artificial substrates, degalactosylated IgA1 and desialylated/degalactosylated IgA1, as compared to the wild-type IgA1 substrate, while the activity with artificial desialylated IgA1 is reduced
-
-
?
additional information
?
-
Neisseria gonorrhoeae ATCC 49226
-
IgA1 exists in forms of monomer, dimer, and oligomer (or polymer) in the physiological conditions and agIgA1 also exists as circulating IgA1-IgG immune complexes in patients with IgAN
-
-
?
additional information
?
-
Neisseria gonorrhoeae ATCC 49226
-
the enzyme activity is several fold higher with artificial substrates, degalactosylated IgA1 and desialylated/degalactosylated IgA1, as compared to the wild-type IgA1 substrate, while the activity with artificial desialylated IgA1 is reduced
-
-
?
additional information
?
-
-
in vitro studies showed that the enzyme also cleaves human chorionic gonadotrophin hormone, granulocyte-macrophage colony stimulating factor, the CD8 surface antigen of cytotoxic T lymphocytes and LAMP 1 a membrane glycoprotein of lysosomes
-
-
?
additional information
?
-
the NMB IgA1 protease shows a broad substrate specificity for human proteins
-
-
?
additional information
?
-
-
the NMB IgA1 protease shows a broad substrate specificity for human proteins
-
-
?
additional information
?
-
the enzyme performs autoproteolysis at the SD domain
-
-
?
additional information
?
-
-
IgA1 exists in forms of monomer, dimer, and oligomer (or polymer) in the physiological conditions and agIgA1 also exists as circulating IgA1-IgG immune complexes in patients with IgAN
-
-
?
additional information
?
-
-
the enzyme activity is several fold higher with artificial substrates, degalactosylated IgA1 and desialylated/degalactosylated IgA1, as compared to the wild-type IgA1 substrate, while the activity with artificial desialylated IgA1 is reduced
-
-
?
additional information
?
-
Neisseria meningitidis ATCC 13090
-
IgA1 exists in forms of monomer, dimer, and oligomer (or polymer) in the physiological conditions and agIgA1 also exists as circulating IgA1-IgG immune complexes in patients with IgAN
-
-
?
additional information
?
-
Neisseria meningitidis ATCC 13090
-
the enzyme activity is several fold higher with artificial substrates, degalactosylated IgA1 and desialylated/degalactosylated IgA1, as compared to the wild-type IgA1 substrate, while the activity with artificial desialylated IgA1 is reduced
-
-
?
additional information
?
-
-
cleavage of p65/RelA occurs at the C-terminal region which contains the transactivation domain (TAD). Removal of the TAD from the rest of the protein may therefore disable the activation capacity of the native p65/RelA molecule
-
-
?
additional information
?
-
-
the enzyme performs autocatalysis at its autocleavage site
-
-
?
additional information
?
-
-
no cleavage of IgA2-IgA1 half hinge, mutants hhS230P, hhS224P, hhS224/230P, hhP227S
-
-
?
additional information
?
-
-
no cleavage of IgA2-IgA1 half hinge, mutants hhS230P, hhS224P, hhS224/230P, hhP227S
-
-
?
additional information
?
-
-
no cleavage of IgA2-IgA1 half hinge, mutants hhS230P, hhS224P, hhS224/230P, hhP227S
-
-
?
additional information
?
-
-
no cleavage of IgA2-IgA1 half hinge, mutants hhS230P, hhS224P, hhS224/230P, hhP227S
-
-
?
additional information
?
-
-
no cleavage of IgA2-IgA1 half hinge, mutants hhS230P, hhS224P, hhS224/230P, hhP227S
-
-
?
additional information
?
-
-
no cleavage of IgA2-IgA1 half hinge, mutants hhS230P, hhS224P, hhS224/230P, hhP227S
-
-
?
additional information
?
-
-
in vitro studies showed that the enzyme also cleaves human chorionic gonadotrophin hormone, granulocyte-macrophage colony stimulating factor, the CD8 surface antigen of cytotoxic T lymphocytes and LAMP 1 a membrane glycoprotein of lysosomes
-
-
?
additional information
?
-
-
no cleavage of IgA2-IgA1 half hinge, mutants hhS230P, hhS224P, hhS224/230P, hhP227S
-
-
?
additional information
?
-
-
no cleavage of IgA2-IgA1 half hinge, mutants hhS230P, hhS224P, hhS224/230P, hhP227S
-
-
?
additional information
?
-
-
no cleavage of IgA2-IgA1 half hinge, mutants hhS230P, hhS224P, hhS224/230P, hhP227S
-
-
?
additional information
?
-
-
no cleavage of IgA2-IgA1 half hinge, mutants hhS230P, hhS224P, hhS224/230P, hhP227S
-
-
?
additional information
?
-
-
no cleavage of mutant hhS230P
-
-
?
